| Aldo Prosperi, MD | |
|
501 Weldon St, Latrobe, PA 15650-1520 | |
| (724) 537-0733 | |
| (724) 537-0860 |
| Full Name | Aldo Prosperi |
|---|---|
| Gender | Male |
| Speciality | Family Practice |
| Experience | 40 Years |
| Location | 501 Weldon St, Latrobe, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1811975527 | NPI | - | NPPES |
| 0010851920002 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD033838E (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Excela Health Home Care & Hospice | Greensburg, PA | Home health agency |
| Excela Health Latrobe Hospital | Latrobe, PA | Hospital |
| Excela Health Westmoreland Regional Hospital | Greensburg, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Excela Health Physician Practices, Inc | 6204737117 | 438 |
News Archive
Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.
"Less than two weeks after Chinese officials released the genetic sequence of a new type of bird flu [H7N9], U.S. vaccine experts are well on the way to making a vaccine to protect people against it," NBC News's "Vitals" blog reports (Fox, 4/10).
Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer's disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.
A new study has shown metformin - a glucose-lowering drug commonly used to treat diabetes - to be effective at lowering some measures of obesity in children and adolescents.
› Verified 2 days ago
| Entity Name | Excela Health Physician Practices, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1821225202 PECOS PAC ID: 6204737117 Enrollment ID: O20040322001393 |
News Archive
Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.
"Less than two weeks after Chinese officials released the genetic sequence of a new type of bird flu [H7N9], U.S. vaccine experts are well on the way to making a vaccine to protect people against it," NBC News's "Vitals" blog reports (Fox, 4/10).
Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer's disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.
A new study has shown metformin - a glucose-lowering drug commonly used to treat diabetes - to be effective at lowering some measures of obesity in children and adolescents.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Aldo Prosperi, MD 520 Jefferson Ave, Jeannette, PA 15644-2538 Ph: (724) 527-8060 | Aldo Prosperi, MD 501 Weldon St, Latrobe, PA 15650-1520 Ph: (724) 537-0733 |
News Archive
Doxorubicin, a 50-year-old chemotherapy drug still in widespread use against a variety of cancers, has long been known to destroy heart tissue, as well as tumors, in some patients.
"Less than two weeks after Chinese officials released the genetic sequence of a new type of bird flu [H7N9], U.S. vaccine experts are well on the way to making a vaccine to protect people against it," NBC News's "Vitals" blog reports (Fox, 4/10).
Proteostasis Therapeutics announced today that modulating a key Proteostasis Network (PN) pathway may offer a novel approach to Alzheimer's disease, a finding that was published in the journal Cell by its scientific founders Andrew Dillin, Ph.D., and Jeffery Kelly, Ph.D. The publication describes how regulation of an aggregase pathway reduced the neurodegenerative effects of beta amyloid aggregates that are a hallmark of the disease.
A new study has shown metformin - a glucose-lowering drug commonly used to treat diabetes - to be effective at lowering some measures of obesity in children and adolescents.
› Verified 2 days ago
Jacob Edward Oslosky, DO Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-961-0359 | |
Luke Egan, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Dr. Christopher C. Drescher, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 | |
Karren Vlahos, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 121 W 2nd Ave, Latrobe, PA 15650 Phone: 724-537-1207 | |
Emily Katherine Fellin, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1 Mellon Way, Latrobe Family Medicine Residency Program, Latrobe, PA 15650 Phone: 724-537-1485 | |
Dr. Francis E Meyers, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 555 Route 217, Suite 5, Latrobe, PA 15650 Phone: 724-694-0274 Fax: 724-694-0383 | |
Dr. Anna Nash Gorman, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 1 Mellon Way, Latrobe, PA 15650 Phone: 724-537-1207 |